http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030040242-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_250c88205716c259f5d89c7c5dbeaa8d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E06B2003-26325 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E06B3-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E06B3-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E06B7-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/E06B3-2632 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 |
| filingDate | 2003-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a6aa662512862abc2a7893e17a1b6a8 |
| publicationDate | 2003-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20030040242-A |
| titleOfInvention | Manufacturing Process of Anthocyanoside Oligomers(85 w/w% above) and Composition Containing Them |
| abstract | The present invention has an excellent effect on the improvement of vision, manufacturing method of extract containing more than 85 w / w% of anthocanoside oligomers (Anthocyanoside Oligomers) used as a raw material for vision improvement medicine, health supplement food, food, etc. To a composition,n n n More specifically, the anthocanoside monomer is obtained from the skin of grapes, and the anthocanoside monomer is added to the fermentation for a certain period of time by adding a mold adapted to a specific medium. After the cyanoside polymer is formed, only 2-5 units of the highest pharmacological activity of the anthocanoside oligomers are selectively separated, and then lyophilized to remove the anthocyanoxide low. Anthocyanoside Oligomers The present invention relates to a method for preparing an extract containing at least 85 w / w% and a food and pharmaceutical composition containing the same.n n n Antocyanoside oligomers of the present invention containing more than 85 w / w% excellent effect on various ophthalmic diseases, namely myopia, hyperopia, astigmatism, night blindness, stable fatigue, central and peripheral retinal degeneration, VDT syndrome, etc. It is expected to be used as a raw material for medicines, health supplements, and foods for vision improvement. |
| priorityDate | 2003-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 208.